AAAAAA
Results: 1-25/56
Authors:
ZADRO R
SUCIC M
AURER I
METELKOKOVACEVIC J
LABAR B
RUKAVINA AS
Citation: R. Zadro et al., ANALYSIS OF CLONALITY IN T-LYMPHOPROLIFERATIVE DISEASES BY MULTIPLEX PCR, CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 36(8), 1998, pp. 637-639
Authors:
LABAR B
NEMET D
MRSIC M
BOGDANIC V
KASSTELAN A
BOBAN D
KALENIC S
RADMAN I
BATINIC D
VRTAR M
GRGICMARKULIN L
MARAVIC N
Citation: B. Labar et al., AUTOLOGOUS VERSUS ALLOGENEIC MARROW TRANSPLANTATION FOR PATIENTS WITHACUTE MYELOID-LEUKEMIA IN 1ST REMISSION, Cancer research, therapy & control, 5(3), 1998, pp. 143-149
Authors:
AURER I
RADMAN I
KOVACEVICMETELKO J
LABAR B
Citation: I. Aurer et al., LYMPHOMA, LEUKEMIA AND MYELOMA, European journal of cancer, 34, 1998, pp. 113-113
Authors:
AURER I
BOGDANIC V
NEMET D
MRSIC M
LABAR B
Citation: I. Aurer et al., ALLOGENEIC STEM-CELL TRANSPLANTATION (ALLOSCT) IN PATIENTS WITH LYMPHOMA RELAPSING AFTER AUTOLOGOUS SCT (AUTOSCT), Annals of oncology, 9, 1998, pp. 549-549
Authors:
SUCIC M
BOBAN D
MARKOVICGLAMOCAK M
BOGDANIC V
NEMET D
LABAR B
CVORISCEC D
PLAVSIC F
STOOSVEIC T
MRSIC M
Citation: M. Sucic et al., RELATION BETWEEN URINARY CYTOLOGY ABNORMALITIES AND CYCLOSPORINE-A THERAPY IN BONE-MARROW TRANSPLANT RECIPIENTS, Renal failure, 20(4), 1998, pp. 613-620
Authors:
BOGDANIC V
AURER I
LABAR B
HITREC V
NEMET D
MRSIC M
Citation: V. Bogdanic et al., TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN RELAPSE AFTER UMBILICAL-CORDBLOOD TRANSPLANTATION, Haematologica, 83(6), 1998, pp. 575-576
Authors:
MRSIC M
LABAR B
BOGDANIC V
NEMET D
RADMAN I
METELKOKOVACEVIC J
AURER I
ZUPANCICSALEK S
SERTIC D
PISK M
Citation: M. Mrsic et al., ALLOGENEIC BMT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS - LONG-TERMSURVIVAL, Bone marrow transplantation, 21, 1998, pp. 19-19
Authors:
DEWITTE T
VANBIEZEN A
HERMANS J
SUCIU S
DARDENNE M
LABAR B
ARCHIMBAUD E
AUL C
SELLESLAG D
FERRANT A
MELONI G
MAURI SB
CARELLA A
LAPORTE J
DEMUYNCK H
NIEDERWIESER D
GRATWOHL A
APPERLEY J
Citation: T. Dewitte et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 37-37
Authors:
BOJANIC I
GOLUBICCEPULIC B
NEMET D
BATINIC D
UZAREVIC B
PETROVECKI M
SKODLAR J
MRSIC M
RADMAN I
LABAR B
Citation: I. Bojanic et al., COLLECTION OF PBSC IN PATIENTS WITH LYMPHOID MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 604-604
Authors:
LABAR B
NEMET D
MRSIC M
RADMAN I
SKODLAR J
BATINIC D
BOGDANIC V
METELKOKOVACEVIC J
AURER I
PETROVECKI M
GOLUBICCEPULIC B
BOJANIC I
PISK M
Citation: B. Labar et al., STEM-CELL TRANSPLANT FOR AGGRESSIVE LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 605-605
Authors:
DEWITTE T
VANBIEZEN A
HERMANS J
SUCIU S
DARDENNE M
LABAR B
ARCHIMBAUD E
AUL C
SELLESLAG D
FERRANT A
MELONI G
MAURI SB
CARELLA A
LAPORTE J
DEMUYNCK H
NIEDERWIESER D
GRATWOHL A
APPERLEY J
Citation: T. Dewitte et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, ON BEHALF OF THE MDS STUDY-GROUP OF THE EBMT CLWP AND THE EORTC-LCG, Bone marrow transplantation, 21, 1998, pp. 750-750
Authors:
RICHTER D
LABAR B
BATINIC D
KELECIC J
RAJIC L
TJESICDRINKOVIC D
MRSIC M
HITREC V
SERTIC J
NOVAK M
Citation: D. Richter et al., DILEMMAS IN POSTTRANSPLANT X-SCID, Molecular immunology, 35(11-12), 1998, pp. 774-774
Authors:
KEATING S
DEWITTE T
SUCIU S
WILLEMZE R
HAYAT M
LABAR B
RESEGOTTI L
FERRINI PR
CARONIA F
DARDENNE M
SOLBU G
PETTI MC
VEGNA ML
MANDELLI F
ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
Authors:
BATINIC D
PETROVECKI M
NEMET D
GOLUBIC B
SKODLAR J
UZAREVIC B
PEROVIC E
BOJANIC I
MRSIC M
BOGDANIC V
LABAR B
Citation: D. Batinic et al., CD34-GM CONTENT DURING PERIPHERAL-BLOOD CD34-POSITIVE SELECTION FOR AUTOLOGOUS TRANSPLANTATION( AND CFU), British Journal of Haematology, 102(1), 1998, pp. 74-75
Authors:
BORANIC M
STANOVIC S
BRELJAK D
KRIZANACBENGEZ L
NEMET D
PETROVECKI M
BATINIC D
SKODLAR J
LABAR B
Citation: M. Boranic et al., PARTICIPATION OF OPIOID-PEPTIDES IN THE CONTROL OF HEMATOPOIESIS, British Journal of Haematology, 102(1), 1998, pp. 165-165
Authors:
DULETICNACINOVI A
PREBILIC MS
LABAR B
COHAR F
Citation: A. Duleticnacinovi et al., COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC GRANULOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 188-188
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH POOR-RISK MDS AND SECUNDARY AML (SAML)
Authors:
DEWITTE T
SUCIU S
VERHOEF G
LABAR B
ARCHIMBAUD E
AUL C
SELLESLAG D
FERRANT A
WIJERMANS P
MANDELLI F
AMADORI S
JEHN U
MUUS P
DEMUYNCK H
DARDENNE M
ZITTOUN R
WILLEMZE R
GRATWOHL A
APPERLEY J
Citation: T. Dewitte et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH POOR-RISK MDS AND SECUNDARY AML (SAML), British Journal of Haematology, 102(1), 1998, pp. 282-282
Authors:
WILLEMZE R
SUCIU S
ARCHIMBAUD E
MUUS P
STRYCKMANS P
LOUWAGIE EA
BERNEMAN Z
TJEAN M
WIJERMANS P
DOHNER H
JEHN U
LABAR B
JAKSIC B
DARDENNE M
ZITTOUN R
Citation: R. Willemze et al., A RANDOMIZED PHASE-II STUDY ON THE EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE COMBINED WITH EITHER AMSACRINE OR IDARUBICIN IN PATIENTS WITH RELAPSEDACUTE-LEUKEMIA - AN EORTC LEUKEMIA COOPERATIVE GROUP PHASE-II STUDY-(06893), Leukemia, 11, 1997, pp. 24-27
Authors:
ZUPANCICSALEK S
RADMAN I
LABAR B
Citation: S. Zupancicsalek et al., PERIOPERATIVE TREATMENT WITH RECOMBINANT FACTOR VIIA IN HEMOPHILIC PATIENT WITH MASSIVE INTRAABDOMINAL BLEEDING, Thrombosis and haemostasis, 1997, pp. 203-203
Authors:
AURER I
MARAVIC N
ZUPANCICSALEK S
RADMAN I
BOGDANIC V
NEMET D
LABAR B
Citation: I. Aurer et al., DIFFERENTIAL EFFECT OF SINGLE-DOSE ESCHERICHIA-COLI L-ASPARAGINASE (ASP) ON GLOBAL COAGULATION PARAMETERS AND ANTITHROMBIN-III (AT3), Thrombosis and haemostasis, 1997, pp. 515-515
Authors:
AURER I
KOVACEVICMETELKO J
RADMAN I
LABAR B
Citation: I. Aurer et al., TREATMENT OF PLASMACYTOMA RELATED BONE PAIN WITH TRAMADOL, Experimental hematology, 25(8), 1997, pp. 428-428
Authors:
HITREC V
LASAN R
LABAR B
Citation: V. Hitrec et al., DETECTION OF RESIDUAL LEUKEMIC-CELLS AFTER BONE-MARROW TRANSPLANTATION BY DOUBLE-COLOR FISH, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 318-318
Authors:
MRSIC S
LABAR B
NEMET D
BOGDANIC V
MRSIC M
RADMAN I
SALEKZUPANCLC S
HITREC V
BOBAN D
MARKOVICGLAMOCAK M
SUCIC M
STAVLJENICRUKAVINA A
Citation: S. Mrsic et al., THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC FINDINGS IN ACUTE MYELOGENOUS LEUKEMIA, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 333-333
Authors:
GERHARTZ HH
ZWIERZINA H
SUCIU S
WALTHER J
DARDENNE M
NEUWIRTOVA R
FENAUX P
BEKSAC M
HAROUSSEAU JL
LOUWAGIE A
THYSS A
FIERE D
COIFFIER B
BAUMELOU F
LABAR B
SOLBU G
WILLEMZE R
Citation: Hh. Gerhartz et al., RANDOMIZED 3-ARM PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/, Blood, 90(10), 1997, pp. 370-370
Authors:
KEATING S
SUCIU S
MANDELLI F
DEWITTE T
WILLEMZE R
ARCHIMBAUD E
HAYAT M
ROTOLI B
LABAR B
RESEGOTTI L
FAZI P
DARDENNE M
ZITTOUN R
Citation: S. Keating et al., AUTOLOGOUS BMT OR PSCT FOR PATIENTS WITH AML IN FIRST CR - A PRELIMINARY-ANALYSIS OF THE AML-10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP (LCG) OF THE EORTC AND GIMEMA, Blood, 90(10), 1997, pp. 1034-1034